Individualized Cell Therapy Systems Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 21 years ago on Friday, August 23, 2002, according to the United State Patent & Trademark Office
Word Mark Individualized Cell Therapy Systems
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Avax International Ip Holdings, Inc. of Wilmington, DE

View all trademarks for Avax International Ip Holdings, Inc.
Other Trademarks for Avax International Ip Holdings, Inc.
Serial Number 76135830
Status Date Friday, August 23, 2002
Filing Date Friday, August 23, 2002
Attorney Amy J. Benjamin

Correspondent

AMY J. BENJAMIN
DARBY & DARBY P.C.
805 3RD AVE
NEW YORK NY 10022-7513

Case File Statements

Goods & Services Cancer Vaccines; Pharmaceuticals for the Treatment of Cancers and Tumors; Autologous Cells, Autologous Cell Cultures and Autologous Cell Vaccines
Goods & Services Medical and Clinical Collection for Transport and Preservation of Tissues and Tumors for Therapeutic Use; Cell Banking; Drug Sensitivity Testing

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, October 16, 2000
Primary Code 005
International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Monday, October 16, 2000
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.